Periodontal Tissue Stability After Surgical Correction of Altered Passive Eruption (NCT07762482) | Clinical Trial Compass
RecruitingNot Applicable
Periodontal Tissue Stability After Surgical Correction of Altered Passive Eruption
Brazil10 participantsStarted 2026-08
Plain-language summary
This prospective, single-group interventional study will evaluate the stability of periodontal tissues after esthetic periodontal surgery for the correction of altered passive eruption in individuals with excessive gingival display. Ten adult participants with excessive gingival display associated with altered passive eruption and involvement of the alveolar bone will be included.
Participants will undergo esthetic crown-lengthening surgery consisting of gingivectomy and osseous recontouring. Periodontal clinical measurements, intraoral digital scans, cone-beam computed tomography, standardized photographs, and patient-reported outcomes will be obtained before surgery and during follow-up. Clinical and three-dimensional tissue changes, esthetic perception, satisfaction, and oral health-related quality of life will be evaluated for up to 12 months after treatment.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults with an esthetic complaint related to excessive gingival display.
* Diagnosis of altered passive eruption as one of the etiologic factors associated with excessive gingival display.
* Altered passive eruption involving the alveolar bone.
Exclusion Criteria:
* Current orthodontic treatment.
* Active periodontal disease.
* Systemic conditions that contraindicate periodontal surgical procedures, including uncontrolled autoimmune diseases.
* Use of medications that may interfere with the inflammatory response or wound healing, including corticosteroids or immunosuppressive agents.
* Current smokers.
* Former smokers who discontinued smoking less than 12 months before enrollment.
* Pregnant or breastfeeding individuals.
* Excessive gingival display primarily associated with lip hypermobility or vertical maxillary excess without concomitant altered passive eruption.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Mean Change From Baseline in Clinical Crown Length
Timeframe: Baseline, 2 weeks, 3 months, 6 months, and 12 months after surgery